- Protocol Short Name and Number: AML T-cell Depletion, 0303
- Protocol Long Name: A Single Arm, Multicenter Phase II Trial of Transplants of HLA-Matched, CD34+ Enriched, T cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients with AML in First or Second Morphologic Complete Remission
- Protocol (PDF)
- Informed Consents
- Frequently Asked Questions
- Key Personnel
- BMT CTN # 0303 Protocol Co-Chair: Richard O’Reilly, MD
- BMT CTN # 0303 Protocol Co-Chair: Steve Devine, MD
- BMT CTN # 0303 Protocol Officer: Marcelo Pasquini, MD
- BMT CTN # 0303 Protocol Coordinator: bmtctn@emmes.com
- BMT CTN # 0303 Medical Monitor: Marcie Riches, MD
- Keywords: Acute Myelogenous Leukemia, AML, CD34+, CD34, CliniMACS, T-cell Depleted, Allo Transplant, Allogeneic Transplant, Allo
This study met its target enrollment and closed accrual on January 11, 2009.